We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




New Test That Accurately Measures DNA Damage in Sperm Could Improve Male Infertility Diagnosis

By LabMedica International staff writers
Posted on 25 Jan 2022

A new test that can measure the amount of DNA damage in sperm with greater accuracy than current tests could significantly improve diagnosis of male infertility, which is more important than ever now that infertility rates are mounting. More...

A team of researchers at Tongji Medical College (Wuhan, China) developed a method that detects the number of DNA breaks in sperm, which in turn enables the calculation of the mean number of DNA breaks (MDB) per sperm in a sample. Current tests only show whether or not sperm have DNA damage and do not measure the amount of damage, even though the latter is essential for a complete evaluation of sperm health. However, this information plays a crucial role in guiding fertility treatments and in selecting high-quality sperm for sperm banks.

The researchers first evaluated their new method using sperm samples from 80 patients, 34 of whom had athenospermia (low sperm motility) and 46 of whom had normal semen. The team compared the ability of MDB to differentiate between athenospermia and normal samples with that of a conventional sperm DNA test that assesses the sperm DNA fragmentation index (DFI). From this, the researchers found that the area under the curve of MDB (0.7932) was higher than that of DFI (0.7631), meaning that MDB did a better job of telling the two sample types apart.

To further evaluate MDB’s clinical utility, the team then used it and DFI to assess 49 semen samples, 22 of which were associated with pregnancy and 27 of which were linked to an inability to get pregnant. The researchers found that the difference in MDB between the pregnant and non-pregnant groups was statistically significant (P=0.0106), while the difference in DFI between the two groups was not significant (P=0.0548). Furthermore, the area under the curve of MDB in this case (0.7576) was once again higher than the area under the curve of DFI (0.6616). Taken altogether, this means that MDB identifies viable sperm that lead to pregnancy with greater accuracy than conventional sperm DNA tests.

“These data indicated that the MDB parameter had stronger clinical relevance with the pregnancy outcomes and our established method could provide a better tool to evaluate sperm quality and male fertility,” said Xianjin Xiao, PhD, of Tongji Medical College, who led the team. “Our method involves direct detection of actual DNA fragmentation, which can measure the specific degree of sperm DNA fragmentation. The method has the advantages of short time-consumption, simple operation, high analytical sensitivity, and low requirement for instruments, which are conducive to the popularization of clinical application.”

Related Links:
Tongji Medical College 


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
Multichem ID-B
New
Integrated Biochemical & Immunological System
Biolumi CX8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.